Skip to Content
You are currently on the new version of our website. Access the old version .
AntioxidantsAntioxidants
  • Article
  • Open Access

7 May 2026

22 Pages

Caffeic Acid Release from Inulin Caffeate: A Comparative Study with Spray-Dried Inulin Microparticles Under Gastrointestinal Digestion

,
,
,
,
and
1
Departamento de Ciencia de los Alimentos y Tecnología Química, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Dr. Carlos Lorca Tobar 964, Independencia, Santiago 81380494, Chile
2
Departamento de Ciencia y Tecnología de los Alimentos, Facultad Tecnológica, Universidad de Santiago de Chile, Av. Víctor Jara 3769, Estación Central, Santiago 9170124, Chile
3
Departamento de Química Orgánica y Fisicoquímica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Dr. Carlos Lorca Tobar 964, Independencia, Santiago 81380494, Chile
4
Departamento de Química Inorgánica y Analítica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Sergio Livingstone, 1007, Independencia, Santiago 8380492, Chile

Abstract

This study compared the physicochemical properties of inulin caffeate, where caffeic acid (CA) was covalently bound to inulin (CA-Inu, degree of substitution: 0.07), with CA spray-dried inulin microparticles (Mp(CA/Inu)), as well as release profiles of CA from CA-Inu and Mp(CA/Inu) under in vitro simulated gastrointestinal digestion. Encapsulation by spray drying was optimized using a Central Composite Design, achieving an encapsulation efficiency of 98%. CA was rapidly released from Mp(CA/Inu) during the oral and gastric phases, followed by a slight decrease in the intestinal phase due to interaction with digestive enzymes. In contrast, no release of CA was detected from CA-Inu during the oral and gastric phases. Approximately 30% was released in the intestinal phase, with a further increase in the colonic phase, especially in the presence of inulinase. This strategy, based on the covalent binding of phenolic compounds to biopolymers, can promote targeted delivery in the later stages of gastrointestinal digestion.

1. Introduction

Currently, there is a significant trend in the food industry focused on innovating polyphenol-rich ingredients for the formulation of healthier food products. Nevertheless, to capitalize on their advantageous effects, it is essential that they preserve their biological activity despite exposure to environmental, food-related, and digestive conditions. Caffeic acid (3,4-dihydroxycinnamic acid; CA), a polyphenol found in coffee, potatoes, berries, honey, olives, carrots, and other sources [1], has shown local therapeutic effects regarding inflammatory bowel disease (IBD) by reducing several pro-inflammatory factors. During the colonic phase, it exhibits the capacity to modulate the microbiota, thereby promoting the production of short-chain fatty acids such as butyric acid, known for its anti-inflammatory properties [2,3] and reducing endotoxemia [4]. However, CA is particularly prone to oxidation at neutral and alkaline pH [5], which limits its ability to exert beneficial effects. Furthermore, it has been demonstrated that CA may interact with digestive enzymes [6,7] and binds to bile salts, contributing to its reduced presence during simulated intestinal digestion [8].
In this context, encapsulation technology by spray-drying is a common strategy for protecting bioactive compounds, such as CA, and enabling their targeted delivery. Spray-drying exhibits a wide range of advantages that make it highly applicable in the food industry, such as its simplicity, low cost, equipment availability, ease of scaling up, and high reproducibility [9]. However, spray drying is more of an immobilization method than an encapsulation one, which makes it necessary to optimize the process in order to achieve high encapsulation efficiency. In addition, high inlet air temperatures are typically used, which can cause the degradation of temperature-sensitive bioactive compounds [9]. On the other hand, its performance is highly dependent on the selection of an appropriate biopolymer, which can limit the achievement of the desired outcomes. Inulin (Inu) has been successfully used as a biopolymer for spray-drying encapsulation of various polyphenolic compounds, including quercetin [10,11,12], epicatechin [10], naringenin [11], olive leaves extract [13], phenol-rich blackcurrant juice [14], phenol-rich Red Dragon Fruit Kombucha [15], anthocyanin-rich strawberry by-products [16], and phenol-rich spent coffee ground extracts [17]. Inulin is a linear chain of β-(2-1) glycosidic linked D-fructose units, typically capped by an α-(2-1) D-glucopyranose unit (G-Fn) [18], exhibiting a wide range of molecular weights depending on the vegetal source, ranging from 50 to 13,000 Da (polymerization degree from 10 to 60) [19]. Human digestive enzymes are unable to digest Inu due to its β-(2,1) glycosidic linkages [20]. Its wide range of molecular weights, indigestibility, and prebiotic effect [21,22,23] make it attractive for several food and pharmaceutical applications, including site-specific vehicles for transporting drugs/bioactive compounds to the colon [24,25].
Another less explored strategy for the targeted delivery of phenolic compounds during digestion involves their immobilization in biopolymers, such as Inu, through chemical functionalization. Esterification between the carboxylic group of CA and the hydroxyl groups of Inu is expected to form a hydrolyzable bond susceptible to both pH and enzymatic action in the gastrointestinal tract, enabling the release of the polyphenol. Consequently, this study hypothesizes that the release of CA in the upper gastrointestinal tract (during the oral and gastric phases) will be reduced by functionalizing Inu with CA, with primary delivery occurring upon reaching the intestine and colon. Inulin has been functionalized with several molecules using different chemical approaches to yield neutral, anionic, and cationic compounds [26,27]. In this context, Inu has also been functionalized with various phenolic compounds, such as p-hydroxycinnamic acid, vanillic acid, and ferulic acid [28,29,30]. However, the performance of these conjugated compounds as oral delivery systems for phenolic compounds has not yet been studied.
The aim of this study was to evaluate the release profile of CA from CA-functionalized Inu (inulin–caffeate, CA-Inu) during in vitro simulated gastrointestinal digestion, and to compare it with the release profile from spray-dried CA Inu microparticles (Mp-(CA/Inu)). Furthermore, the functionalization of Inu with CA was confirmed by proton nuclear magnetic resonance (1H-NMR), and the degree of substitution was determined. Both CA-Inu and Mp-(CA/Inu) were also characterized in terms of their physicochemical, thermal, and morphological properties.

2. Materials and Methods

2.1. Materials

Caffeic acid (3-(3,4-dihydroxyphenyl)-2-propenoic acid, CA) 98%, triphenyl phosphine (TPP) 98%, diisopropyl azodicarboxylate (DIAD) 98% and Amberlyst 15 were obtained from AK Scientific (Union City, CA, USA). Inulin Orafti® HP (degree of polymerization, DP ≥ 23, Inu) was obtained from Blumos S.A. (Santiago, Chile). Pepsin was obtained from porcine gastric mucosa (P6887, 1162 ± 247 U/mg), pancreatin from porcine pancreas (P7545, 8 × USP specifications, 5.8 ± 0.7 U/mg trypsin and 60 ± 3 U/mg lipase), and bile extract (B8631), triphenylphosphine, sodium methoxide, guanidine nitrate, 2,2′-Azobis(2-methylpropionamidine) dihydrochloride (AAPH), and 6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) were purchased from Sigma-Aldrich (Santiago, Chile). The fructanase mixture (E-FRMXPD, 420 U/mg) was obtained from Megazyme Neogen (Santiago, Chile). Sodium carbonate, sodium hydroxide, sodium sulfate, acetic anhydride for analysis, dichloromethane for analysis, ethyl acetate for analysis, N-N-dimethylformamide, formic acid for analysis, fluorescein sodium and Folin reagent were acquired from Merck Millipore (Santiago, Chile). Dimethylsulfoxide-d6 (d6-DMSO, 99.8%) was obtained from Zeotope, Zeochem AG (Rüti, Switzerland). Finally, methanol for HPLC gradient and ethanol absolute for analysis were purchased from AppliChem Panreac (Santiago, Chile).

2.2. Synthesis of Inulin Caffeate

The synthesis of caffeic acid-functionalized inulin (inulin caffeate, CA-Inu) was performed in three steps. Initially, CA was protected by acetylation with acetic anhydride (di-O-CA) [31]. Then, the protected CA was esterified to Inu using a modified Mitsunobu coupling (di-O-CA-Inu) [32]. Finally, CA-Inu was obtained by deprotecting the diacetylcaffeic moieties with guanidinium/guanidine system [33] (Figure 1).
Figure 1. Synthetic pathway used for the synthesis of inulin caffeate (CA-Inu).

2.2.1. Synthesis of 3,4-Diacetylcaffeic Acid

In a 250 mL double neck round-bottom flask with a magnetic stirrer, 10 g of CA (55.5 mmol, 1 equiv.) were weighed. The flask was sealed with a rubber septa and purged with nitrogen. Then, 150 mL of 1 M NaOH were added with a syringe. The mixture was stirred in an ice bath for 5 min, and 20 mL of acetic anhydride were added, which yielded a white precipitate. After 30 min, the mixture was filtered through a glass frit and washed with cold water. The product (3,4-diacetylcaffeic acid, di-O-CA) was recrystallized in 150 mL of hot ethanol, filtered, and rinsed with cold ethanol.
1H-NMR, δ ppm, d6-DMSO: H1: 12.78 (s, 1H, –COOH); H2: 7.67 (d, J = 2.2 Hz, 1H, Ar-H); H3: 7.64 (dd, J = 2.2 Hz, J = 7.4 Hz, 1H, Ar-H); H4: 7.58 (d, J = 16.1 Hz, 1H, =CH–); H5: 7.32 (d, J = 8.3 Hz, 1H, Ar-H); H6: 6.54 (d, J = 16.0 Hz, 1H, –CH=); H7: 2.30 (s, 3H, –OOC–CH3); H8: 2.31 (s, 3H, –OOC–CH3).

2.2.2. Synthesis of Inulin-3,4-Diacetylcaffeate

Dry Inu (5 g, 30.8 mmol, 2 equiv. based on the fructosyl unit), 3,4-diacetylcaffeic acid (4.07 g, 15.4 mmol, 1 equiv.), and triphenylphosphine (TPP, 4.44 g, 16.94 mmol, 1.1 equiv.) were each dissolved in anhydrous N,N-Dimethylformamide (DMF) (60 mL, 40 mL, and 40 mL, respectively) at 80 °C, and then they were transferred into a flame-dried 250 mL double neck round-bottom flask sealed with rubber septa, purged with nitrogen and stirred in a salt-ice bath for 10 min. DIAD (3.33 mL, 3.43 g, 16.94 mmol, 1.1 equiv.) were added dropwise with a syringe. The mixture was left to reach room temperature and was stirred under nitrogen overnight. Water (50 mL) was added to quench the unreacted TPP/DIAD. The DMF was removed from the reaction mixture by rotary evaporation at 60 °C and 20 mbar (Rotavapor® R-100, Büchi, Switzerland). The concentrated mixture was dissolved in water, and the organic by-products were extracted with ethyl acetate. The aqueous fraction was rotary evaporated. The remaining solid was dissolved in hot water and then poured dropwise over an excess of vigorously stirred cold acetone to reprecipitate inulin-3,4-diacetylcaffeate (di-O-CA-Inu).
1H-NMR, δ ppm, d6-DMSO: H1: 7.67 (m, 3H, Ar-H, =CH–); H2: 7.33 (d, J = 8.4 Hz, 1H, Ar-H); H3: 6.69 (d, J = 16.3 Hz, 1H, =CH–); H4: 5.15 (d, J = 5.4 Hz, 1H, –OH); H5: 4.7 (d, J = 6.6 Hz, 1H, –OH); H6: 4.61 (s, 1H, –OH); H7: 4.07 (m, –CH–); H8: 3.81 (m, –CH–); H8: 3.52 (m, –CH–); H9: 2.29 (s, 3H, –OOC–CH3); H10: 2.29 (s, 3H, –OOC–CH3).

2.2.3. Synthesis of Inulin Caffeate

Inulin-3,4-diacetylcaffeate (di-O-CA-Inu, 5 g) was dissolved in 100 mL methanol, and added dropwise to a strongly stirred guanidine/guanidinium solution (2.488 g of guanidine nitrate, 4 mL of 1M MeONa in MeOH, and 200 mL of CH2Cl2/MeOH 1:9) [34]. The phenolate form of inulin-(E)-3-(3,4-dihydroxyphenyl) acrylate precipitated as a yellow solid, which, after 15–30 min, was centrifuged at 4460× g for 20 min, rinsed with methanol and vacuum-dried. The solid was dissolved in water:methanol (1:1 v/v), and Amberlyst 15 in its acid form was slowly added until a pH of 6–7 was reached. The Amberlyst 15 was then filtered off and rinsed. The solution was rotary evaporated to dryness using a rotary evaporator. The resulting solid was then dissolved in deionized water (300 mg per 20 mL tube) and dialyzed against 2 L deionized water using Pur-A-Lyzer™ Mega dialysis tubes (Sigma-Aldrich, Rehovot, Israel) with a molecular weight cutoff (MWCO) of 1 kDa for 2 days, changing the external reservoir water twice. Finally, the dialyzed sample (~20 mL) was frozen at −20°C overnight and lyophilized at 0.2 mbar for 2 days in a freeze dryer (Lyovapor L-200, Büchi, Switzerland) to obtain CA-Inu.
1H-NMR, δ ppm, d6-DMSO: H1: 9.58 (s, 1H, Ar-OH); H2: 9.13 (s, 1H, Ar-OH); H3: 7.50 (d, J = 15.6 Hz, 1H, =CH–); H4: 7.05 (s, 1H, Ar-H); H5: 7.01 (s, 1H, Ar-H); H6: 6.76 (d, J = 8.0 Hz, 1H, Ar-H); H7: 6.32 (d, J = 15.7 Hz, 1H, =CH–); H8: 5.15 (d, J = 5.4 Hz, 1H, –OH); H9: 4.71 (d, J = 6.6 Hz, 1H, –OH); H10: 4.62 (s, 1H, –OH); H11: 4.05 (m, –CH–); H12: 3.81 (m, –CH–); H13: 3.52 (m, –CH–).

2.3. Characterization of Inulin Caffeate

CA-Inu was characterized according to the following parameters.

2.3.1. Proton Nuclear Magnetic Resonance

1H-NMR spectra were obtained from a Bruker AVANCE DRX 300 (Karlsruhe, Germany) spectrometer operating at 300.13 MHz. Measurements were carried out at a probe temperature of 300 K, using d6-DMSO. The sample was treated overnight with molecular sieves to eliminate the presence of water. The sieves were removed before acquiring the spectra.

2.3.2. Attenuated Total Reflection Fourier Transform Infrared Spectroscopy (ATR-FTIR)

Infrared absorption spectra were measured on the neat solid samples using a single reflection germanium prism ATR (Attenuated Total Reflectance) accessory (Miracle, PIKE, Madison, WI, USA) in a Fourier transform infrared spectrometer (Nicolet iS50R, Thermo Fisher Scientific, Madison, WI, USA) covering the spectral range from 4000 to 800 cm−1. The spectra were corrected by intrinsic ATR effects on band absorption intensity and peak shift effects using the spectrometer software (OMNIC v9.7.39).

2.3.3. Degree of Substitution (DS)

DS was determined by 1H-NMR spectroscopy and Folin–Ciocalteu colorimetric assay.
1H-NMR: Two zones were used between 3.0 and 4.4 ppm, corresponding to the alkyl protons of the fructosyl moieties (7 protons total), and the range 6.0 to 8.0 ppm, corresponding to three aromatic protons and two allylic protons of the CA moiety (5 protons total). DS can range from zero (no substitution) to three (esterification of the three hydroxyls of the fructosyl moiety) (Equation (1)):
D S N M R = A r e a   a l l y l i c + a r o m a t i c   p r o t o n s 5 × 7 A r e a   a l l y l i c   p r o t o n s
Folin–Ciocalteu: The total phenolic content of CA-Inu was determined through a modified method at a milder pH [35]. Briefly, 150 μL of the sample were added to 750 μL of Folin reagent (2 N) diluted in Milli-Q water at a 1:30 ratio (67 mM) and mixed for 5 min. Then, 600 μL of Na2CO3 0.75% w/v was added, and the mixture was incubated for 2 h in the dark at room temperature. Transmittance was measured at a wavelength of 760 nm in a dual-beam UV–Vis spectrophotometer (Halo DB-20, Dynamica, UK). The DS was obtained by quantifying the amount of caffeoyl groups using a caffeic acid calibration curve (2.5 to 100 ppm, R2 = 0.999).

2.4. Encapsulation of Caffeic Acid with Inulin by Spray Drying

A Central Composite Design (CCD) with 4 central points (α = 1.21), 4 experimental points and 4 axial points was applied to optimize the CA encapsulation with Inu by spray-drying. The independent variables were the CA content (0.27 to 0.93 g per 100 g infeed) and the inlet air temperature (127 to 193 °C), which falls within the range of temperatures generally reported for spray drying (110–220 °C) [36]. The dependent variable was the encapsulation efficiency (EE) of CA.
The infeed dispersion (100 g) was prepared by dissolving Inu (10 g) in 80 mL of deionized water under magnetic stirring and heated up to 85 °C in a water bath until total solubilization. CA (0.27 to 0.93 g) was dissolved in hot ethanol (9.73 to 9.07 g), and then it was added to the hot Inu solution and stirred for 5 min at 85 °C. The infeed was fed into a spray dryer (Mini Spray dryer B-290, Büchi, Switzerland) at 60 °C, stirring at 250 rpm (Heidolph MR-Hei, Heidolph Inst. GmbH, Schawabach,Germany). The spray-drying process conditions were: inlet airflow of 600 L/h, atomization pressure of 2 psi, feeding rate of 1 mL/min, and the inlet air temperature was set according to experimental design.
Response surface methodology was applied to optimize (maximize) the EE of CA. Analysis of variance (ANOVA), lack of fit test, and determination of the regression coefficients were performed using the software Statgraphics (7.0 version, Manugistics Inc., Rockville, WI, USA). Data were fit to a second-order regression model (Equation (2)), considering linear, quadratic, and cross-product forms of the inlet air temperature and CA content:
E E = β 0 + β 1 X 1 + β 2 X 2 + β 12 X 1 X 2 + β 11 X 12 + β 22 X 22 + ϵ
where EE was the estimated response; X 1 and X 2 are the levels of the independent variables; β 0 was the intercept term; β 1 and β 2   the linear coefficients; β 12 the interaction coefficient; β 11 and β 22 the quadratic coefficients and ϵ the error.

Encapsulation Efficiency

Total caffeic acid: Caffeic acid–inulin microparticles (Mp(CA/Inu); 100 mg) were dispersed in 2 mL of methanol, vortexed (FineVortex, FinePCR, Gunpo-si, Republic of Korea), sonicated (Elmasonic E 30 H, Elma-Hans Schmidbauer GmbH, Singen, Germany) for 5 min, and centrifuged (Hettich Universal 320R, Tuttlingen, Germany) at 9060× g for 10 min. The pellet was extracted twice following the same methodology. The supernatants were combined and filled to 10 mL before being injected into the HPLC.
Surface caffeic acid: Mp(CA/Inu) (100 mg) was dispersed in 4 mL of ethyl acetate:ethanol (2:1 v/v), gently stirred for 1 min, and filtered in a 0.22 μm PTFE syringe filter (Macherey-Nagel GmbH, Düren, Germany). The filtrate (2 mL) was vacuum-dried, redissolved in methanol, and injected into the HPLC.
Caffeic acid chromatographic analysis: CA quantification was performed by HPLC using an Alliance e2695 chromatograph (Waters, Milford, MA, USA), equipped with a photodiode-array detector (Waters 2998, Waters, Milford, MA, USA) and a C18 column (5 μm, 4.6 mm i.d. ×250 mm, Symmetry, Waters, Dublin, Ireland). The mobile phases consisted of solvent A (Milli-Q water) and solvent B (methanol with 0.4% formic acid), with a flow rate of 0.8 mL/min. The gradient elution profile was set as follows: 30% B (0 to 3 min), 50% B (3 to 5 min) and 30% B (5 to 10 min). CA was quantified using a calibration curve (1 to 100 µg/mL, R2 = 0.999). Chromatograms were recorded at 325 nm with an injection volume of 20 µL.
The EE of CA was determined using Equation (3):
E E   % =   T o t a l   c a f f e i c   a c i d   − S u r f a c e   c a f f e i c   a c i d T o t a l   c a f f e i c   a c i d   × 100

2.5. Characterization of Inulin Caffeate and Caffeic Acid–Inulin Microparticles

CA-Inu and Mp(CA/Inu) were characterized according to the following parameters.

2.5.1. Wide-Angle X-Ray Scattering (WAXS)

WAXS patterns for CA-Inu and Mp(CA/Inu) were obtained in a laboratory beamline SAXS/WAXS/GISAXS system (SAXSPoint 2.0, Anton Paar, Graz, Austria), using a Cu-Kα microfocus source (Anton Paar, Primux 100) with a copper anode and Astix optics, obtaining a point-collimated parallel beam with wavelength CuKα = 1.5418 Å. It has a 2D detector (Dectris, Eiger R 1 M) with a sample-to-detector distance ranging from 115 mm (WAXS) to 562 mm (SAXS). The samples (CA-Inu and Mp(CA/Inu)) were confined in sealed 1.0 mm diameter special glass capillaries (Charles Supper Company, Natick, MA, USA). Data acquisition was performed using SAXSDrive software v2.02.295.15850 (Anton Paar, Austria), capturing a single frame with a 900 s exposition at a sample-to-detector distance of 115 mm. The data was subsequently reduced using SAXSAnalysis software v4.20.048.15546 (Anton Paar, Austria) following transmission correction and background subtraction, resulting in intensity vs. 2θ X-ray scattering patterns.

2.5.2. Thermal Analysis

The thermal behavior of CA-Inu and Mp(CA/Inu) was studied with a TA Q20 differential scanning calorimeter (TA Instruments-Waters LL, Delaware, DE, USA). The samples were confined in Tzero® aluminum pans (TA Instruments-Waters LL, Delaware, DE, USA) and, both the sealed and non-sealed pan, were measured in Modulated Differential Scanning Calorimetry (MDSC) mode with a 1.5 °C/min heating rate using a sinusoidal temperature modulation of 1.5 °C amplitude and 90 s period. The thermograms were processed with Universal Analysis v4.5A software (TA Instruments-Waters LL, Delaware, DE, USA).

2.5.3. Morphology

The morphology of CA-Inu and Mp(CA/Inu) was evaluated by scanning electron microscopy (SEM) using a high-resolution scanning electron microscopy (FE-255 SEM, Inspect-F50, FEI, Eindhoven, The Netherlands) with a secondary electron detector operated at 2 kV. The samples were gold sputtered with a Sputter Coater (Cressington model 108, Ted Pella Inc., Redding, CA, USA) equipped with a thickness controller (Cressington MTM-20) at a thickness of 10 nm. Images were captured and processed with xT Microscope Control software (FEI, Hillsboro, OR, USA), version 4.1.13.2167.

2.5.4. Moisture, Hygroscopicity, and Water Activity

The moisture content was determined gravimetrically [12]. Samples (CA-Inu and Mp(CA/Inu)) were weighed in a clock glass and dried in a forced convection oven (BE 500, Memmert®, Schwabach, Germany) at 105 °C until a constant mass was reached. The water activity of the samples (1 g) was measured by determining the dew point (Hygrolab2, Rotronic, Hauppauge, NY, USA) at 20 ± 3 °C. The hygroscopicity was measured gravimetrically [12]. Samples (100 mg) in a clock glass were placed in a desiccator with Na2SO4 (81% relative humidity) for one week at 25 °C.

2.5.5. Solubility

The solubility of CA-Inu and Mp(CA/Inu) was determined gravimetrically [12]. Samples (100 mg) were dispersed in distilled water (10 mL), stirred for 5 min, and centrifuged at 1100× g for 5 min. An aliquot (2.5 mL) was dried at 105 °C in an oven (BE 500, Memmert®, Schwabach, Germany) for 5 h. The weight of the dried soluble solid was recorded, and solubility was expressed as a percentage.

2.5.6. Particle Size

The particle size and size distribution of Mp(CA/Inu) were analyzed by light scattering using a laser scattering particle size analyzer (Partica LA-960, Horiba, Kyoto, Japan; 650 nm laser diode). The microparticles were measured as dry powder using PowderJet (Horiba, Kyoto, Japan) with compressed air at 0.30 MPa (3 bar). The particle size was expressed as the mean particle size (D4,3).

2.5.7. Antioxidant Activity

The oxygen radical absorbance capacity (ORAC) was measured for CA-Inu and Mp(CA/Inu) [37]. Fluorescein sodium (65.5 nM) and 2,2′-Azobis(2-methylpropionamidine) dihydrochloride (AAPH, 150 mM) were dissolved in phosphate buffer (pH 7.4). A standard curve of Trolox was prepared in the range of 15 to 150 µM (normalized area = 15.7·[Trolox] (µM) + 393.6, R2 = 0.9986). The assay was performed in a 96-well dark microplate in a multi-mode reader (Synergy HTX, BioTek, Winooski, VT, USA) with fluorescence filters (excitation and emission wavelengths of 485 and 520 nm, respectively). Trolox curve points, 25 µL of each sample, and blanks were added to the microplate in quadruplicate. Then, 150 µL of fluorescein were added to the samples, shaken for 50 s, and incubated for 3 min at 40 °C. Subsequently, 25 µL of AAPH were added, and fluorescence decay was recorded every minute at 40 °C. The area under the fluorescence curve for each sample was integrated and interpolated into the Trolox calibration curve. The antioxidant capacity was expressed as µmol Trolox/mg CA.
In the presence of antioxidants (AOX), the decrease in fluorescence shows an induction time (ti), given by Equation (4) [38,39]:
t i = n × A O X R i
where the parameter n is the stoichiometric number, which is defined as the moles of radicals scavenged by each antioxidant molecule, [AOX] is the antioxidant concentration, and Ri is the rate of radical generation from the APPH initiator.

2.6. Simulated In Vitro Digestion

CA-Inu and Mp(CA/Inu) underwent successive oral, gastric, and intestinal digestion phases according to the INFOGEST protocol 2.0 [40]. CA was also subjected to digestion for comparative purposes. Gastrointestinal digestion was carried out in a 50 mL water-jacketed beaker maintained at 37 °C with a JSRC-13C recirculating chiller (JS Research Inc., Gongju, Republic of Korea), and stirred with a Heidolph MR-Hei Standard magnetic stirrer (Heidolph Instruments GmbH, Schwabach, Germany).
Oral phase: CA (3.68 mg), CA-Inu (53 mg, containing 3.68 mg CA) and Mp(CA/Inu) (100 mg, containing 3.68 mg of CA) were dispersed in water (4.9 mL), and 4 mL of simulated salivary fluid (SSF) were added. Then, 25 µL of 0.3 M CaCl2 and 0.975 mL of water were added to achieve a final volume of 10 mL. The mixture was incubated at 37 °C for 2 min at 250 rpm. At the end of the oral digestion, a 500 µL aliquot was extracted.
Gastric phase: To the remaining 9.5 mL of the oral phase, 7.6 mL of simulated gastric fluid (SGF) was added, and the pH was adjusted to 2.0 with 1 M HCl. Then, 4.8 µL of 0.3 M CaCl2 and 11.62 mg of porcine pepsin (2000 U/mL gastric phase) were added. Distilled water was added to complete the total volume of 19 mL for gastric digestion. The mixture was then incubated at 37 °C for 2 h at 250 rpm. Aliquots (500 µL) were taken every 30 min.
Intestinal phase: To the remaining 18 mL of gastric digest, 7.65 mL of simulated intestinal fluid (SIF) and 36 µL 0.3 M CaCl2 were added, adjusting the pH to 7 using 1 M NaOH. Then, 482 mg of pancreatin (trypsin activity of 100 U/mL intestinal phase), and 420 mg of bile were dispersed separately in SIF and added to the intestinal digestion. Distilled water was added to bring the final volume to 36 mL. The mixture was incubated at 37 °C for 2 h at 250 rpm. Aliquots (500 µL) were taken at various time points.
Colonic phase: The colonic phase is not included in the INFOGEST protocol. It was simulated by incubating the final intestinal digest with inulinase (Fructanase®, Megazyme Neogen, Santiago, Chile) instead of fecal inoculum, as follows. After the intestinal phase, 10 mL of the digested sample were transferred to a 25 mL capped laboratory bottle. Then, 125 U of inulinase (5 U/mg Inu) was added to the mixture, which was subsequently incubated for 24 h at 37 °C using a JSSI-100C orbital shaker (JS Research, Korea). Aliquots of 250 µL were taken at 1, 3, 6, 18, and 24 h.

Quantification of Caffeic Acid Released During Digestion

The quantification of released CA in the digestion aliquots involved gentle centrifugation at 2430× g to avoid cracking the remaining microparticles. An aliquot of the supernatant (100 µL) was diluted with 900 µL of methanol, acidified with 2.5 µL of formic acid, and vortexed. The samples were then centrifuged at 14,000× g to remove any remaining Inu or bile residues, filtered through a 13 mm 0.22 μm pore size PTFE syringe filter (Macherey-Nagel GmbH, Düren, Germany), and injected as described in the section Encapsulation Efficiency.

3. Results

3.1. Synthesis and Characterization of the Caffeic Acid-Functionalized Inulin (Inulin Caffeate)

Steglich and Mitsunobu esterification have been reported to prepare caffeates with different monomeric substrates [41]. However, this approach was unsuccessful to obtain CA-Inu directly from CA and Inu. As an alternative, CA has been protected by acetylation in the synthesis of other caffeates [31,42], such as inulin cinnamate, p-hydroxicinnamate, vanillate and inulin ferulate [28,29,30]. This strategy was selected due to the rapid and easy removal of acetyl moieties without affecting the CA-Inu. Steglich coupling with the protected CA yielded several side reaction products compared to Mitsunobu. Therefore, the functionalization of Inu with CA was performed in three steps: protection of CA to obtain 3,4-diacetylcaffeic acid (di-O-CA), followed by Mitsunobu esterification of Inu to inulin-3,4-diacetylcaffeate (di-O-CA-Inu), and finally deprotection of the hydroxyl groups to obtain CA-Inu (Figure 1).

3.1.1. Proton Nuclear Magnetic Resonance

The 1H-NMR spectra are summarized in Figure 2a and Figure S1. CA and the protected CA with the acetyl groups are in good agreement with the literature [31]. The acetylation of caffeic acid (di-O-CA) caused a shift in several signals in the allylic/aromatic zone (6 to 8 ppm), the disappearance of the CA phenolic protons (9.13 and 9.52 ppm), and the appearance of a signal at 2.30 ppm for the –CH3 of the acetyl groups. The covalent linking of di-O-CA to Inu (di-O-CA-Inu) was confirmed by several changes: a slight shift in the allylic protons from 6.54 and 7.58 ppm in di-O-CA to 6.68 and 7.63 ppm in di-O-CA-Inu. Also, an overall broadening of the caffeate moiety signals (between 6.6 and 7.2 ppm) was observed due to the loss of mobility, while the signals of the 6 protons of the acetyl groups remained unchanged at 2.29 ppm. Moreover, the absence of the carboxylic proton was also observed, which was previously visible on CA and di-O-CA.
Figure 2. 1H-NMR (300 MHz in d6-DMSO at 20 °C) and ATR-FTIR (single-reflection Ge prism, 25 °C) spectra. (a) 1H-NMR spectra for inulin (Inu), caffeic acid (CA), inulin di-o-acetylcaffeate (di-O-CA-Inu) and inulin caffeate (CA-Inu). (b) Comparison of Inu and CA-Inu showing the presence of new signals arising from the caffeate moiety. (c) Comparison of CA-Inu and CA, showing the carbonyl stretching signal shift after esterification.
For the deprotected CA-Inu, the removal of the acetyl protection was confirmed by the disappearance of the 2.29 ppm signal, with the appearance of the phenolic protons at 9.13 and 9.58 ppm. Additionally, the signals for the allylic and aromatic protons reverted to a pattern similar to CA, with slight chemical displacement shift, peak broadening and absence of the carboxylic proton. Regarding the pattern of the Inu backbone, it remained stable throughout the synthesis, as can be observed for Inu, di-O-CA-Inu, and CA-Inu (Figure 2a). These experiments were carried out in d6-DMSO, which allowed the observation of signals from Inu (4.5 to 5.5 ppm), and CA and di-O-CA moiety (6–13 ppm), since d6-DMSO is an aprotic solvent.

3.1.2. Attenuated Total Reflection Fourier Transform Infrared Spectroscopy (ATR-FTIR)

Infrared spectroscopy (Figure 2b,c) clearly indicated the presence of the caffeic moiety, despite the relatively low substitution degree. In Figure 2c, the νν C=O of the ester in CA-Inu appears at 1685 cm−1, while the νν C=C from the CA aromatic ring and allylic group appears at 1634, 1607 and 1517 cm−1. Full FTIR spectra for Inu, Mp(CA/Inu), CA-Inu, and CA is shown as Figure S2.

3.1.3. Degree of Substitution

The DS of CA-Inu was determined using both 1H-NMR spectroscopy and the Folin–Ciocalteu assay. For the 1H-NMR spectra, the DS was calculated based on the ratio of aromatic to aliphatic signals from the caffeoyl moiety. The DS of CA-Inu was 0.07, as determined by 1H-NMR, and 0.08 using the Folin–Ciocalteu assay. The synthesis of similar compounds has been reported in the literature, such as totally substituted inulin cinnamate (DS 3.0) [28]; inulin p-hydroxycinnamate with different DS, ranging from 0.37 to 1.13 [30]; inulin vanillate with different DS ranging from 0.38 to 0.98 [30]; inulin ferulate with different DS ranging from 0.42 to 1.12 [29,30]. All these studies reported DS values are higher than that reported for CA-Inu in this work (DS 0.07).

3.2. Encapsulation of Caffeic Acid with Inulin

Microencapsulation of CA with Inu by spray-drying Mp(CA/Inu) was performed using a CCD with axial points. The influence of CA content (formulation variable) and inlet air temperature (operational variable) on the EE of CA was studied. Table 1 shows the experimental design for the encapsulation of CA with Inu by spray-drying, and the analysis of the variance (ANOVA) for EE of CA.
Table 1. Composite central design for encapsulation of caffeic acid with inulin by spray-drying, and analysis of variance (ANOVA) for encapsulation efficiency.
The EE of CA is an important parameter that represents the interaction of CA with Inu. The EE varied from 45.9% to 99.8% (Table 1), which were within the range of values reported in previous research for extracts containing CA. For example, spray-dried microparticles of spent coffee ground extracts had an EE of CA of 63% when inulin:maltodextrin (80:20 wt) was used as encapsulating agent [17]. A high EE of CA (86%) was reported for microparticles of green coffee extract with maltodextrin and skim milk from whole coffee fruit [43].
The ANOVA (Table 1) showed that both the linear and quadratic forms of CA and inlet air temperature, as well as the interaction between the CA and inlet air temperature, were significant (p ≤ 0.05) for the EE of CA. Moreover, 88.45% of the variability (R2 adj. for d.f.) was explained by the model with a non-significant lack-of-fit (p ≥ 0.05). Among the significant factors, the CA content had the greatest influence on the EE (p = 0.0005).
The response surface graph for the EE of CA with Inu (Figure S3) showed that EE was higher in microparticles with lower CA content. The Inu content was the same for all the experimental runs; therefore, the available Inu hydroxyl groups to form hydrogen bonds with CA increased as the CA content decreased, therefore increasing the EE. Additionally, the EE slightly increased when the inlet air temperature increased, which may be explained by the fact that higher inlet air temperature forms a crust more rapidly on the droplet surface, retaining CA and thereby increasing the EE. In addition, the X-ray diffraction pattern of the Mp(CA/Inu) with the lowest EE of CA showed diffraction peaks corresponding to crystalline CA (Figure S4). When the surface CA (non-encapsulated) was removed by washing with ethyl acetate:ethanol (2:1), these crystalline peaks disappeared, confirming that the EE decreased with lower drying temperatures and higher caffeic acid loads by CA crystallization in the feed solution. To maximize the EE, the optimal inlet air temperature was 167 °C, and the CA in 100 g of infeed was 0.39 g. Under these conditions, the model predicted 100% of EE.

3.3. Characterization of Microparticles of Caffeic Acid with Inulin and Caffeate-Inulin

Table 2 shows the physico-chemical and thermal characterization of CA-Inu and Mp(CA/Inu).
Table 2. Physicochemical and thermal properties of caffeic acid–inulin microparticles and inulin caffeate.

3.3.1. X-Ray Diffraction

Figure 3 shows the diffraction pattern for CA, CA-Inu and Mp(CA/Inu). CA-Inu showed a semicrystalline pattern corresponding to Inu in its monohydrate crystal form [44]. On the contrary, Mp(CA/Inu) showed a typical amorphous diffraction pattern, without CA diffraction peaks, indicating that the CA was well dispersed in the amorphous Inu matrix. To assess the influence of CA on the diffraction pattern, spray-dried and freeze-dried Inu powders were prepared as controls. The crystalline structure of CA-Inu resembled that of freeze-dried Inu (8.2°, 12.2°, 16.5°, 18.1°, 19.2°, 22.0°, and 24.6°), and the characteristic peaks of CA were not observed due to the covalent bonding of CA to Inu. The almost identical crystalline structure indicated that the low DS (0.07) did not significantly affect the diffraction pattern. However, a higher amorphous content and broader peaks were noticed in CA-Inu, suggesting that the incorporation of CA in Inu negatively impacts crystal formation and growth. Mp(CA/Inu) and its control (spray-dried Inu) were amorphous, although the Mp(CA/Inu) showed higher amorphous content attributed to the dispersed CA.
Figure 3. X-ray diffraction pattern for, CA, inulin caffeate (CA-Inu), Mp(CA/Inu), and spray-dried and freeze-dried inulin (Inu).

3.3.2. Thermal Behavior

The thermal behavior of spray-dried Inu, Mp(CA/Inu), and CA-Inu was evaluated using the MDSC technique in non-sealed and hermetic aluminum pans (Figure 4a–d). The total heat flow of pure CA obtained by conventional DSC is provided in Figure S5, showing a melting peak at 217.97 °C, followed by an exothermic decomposition event. Since this transition lies outside the temperature range investigated for the Inu-containing samples, no further analysis was performed.
Figure 4. MDSC thermograms for caffeic acid/inulin microparticles (MP(CA/Inu)) and inulin caffeate (CA-Inu) and inulin (Inu). (a) Non-reversible heat flow non-sealed pan; (b) reversible heat flow non-sealed pan; (c) non-reversible heat flow sealed pan; (d) reversible heat flow sealed pan.
Non-hermetic condition: the samples measured in non-sealed pans should reflect the intrinsic behavior of the Inu without the plasticizing effect of moisture, since the water loss was observed as a broad peak ranging from 0 °C to 140 °C (Figure 4a) in the three samples. Spray-dried Inu showed a glass transition temperature (Tg) of 157 °C (Figure 4b), which is consistent to the Tg values of 150 °C and 148 °C reported in the literature [45,46]. The incorporation of CA in the Inu matrix affected the Tg values, decreasing in the case of Mp(CA/Inu) to 136 °C, and increasing for CA-Inu to 162 °C. The decrease in Tg observed for Mp(CA/Inu) may be explained by the fact that the feed solution reached a pH ~3.5, which has been reported to hydrolyze Inu at the temperatures used [47]. However, the 1H-NMR of the spray-dried powder did not show monomeric fructose or a significant effect on the Inu signals. Despite this, a decrease in the molecular weight distribution of the chains cannot be ruled out, which could explain the observed decrease in the Tg temperature. For CA-Inu, the increase in Tg value can be attributed to the strengthened interactions between the phenolic moieties and the Inu hydroxyl groups through hydrogen bonds. Additionally, the dialysis process used for purification likely contributed to the Tg increase by removing low molecular weight chains that can permeate the membrane (MWCO 1000), thus shifting the molecular weight distribution to higher values. CA-Inu showed a melting event concurrent with the glass transition (Figure 4a,b), consistent with the crystalline peaks observed in its diffraction pattern (Figure 3). No cold crystallization was observed for CA-Inu and Mp(CA/Inu) (Figure 4b), which is expected since both Inu crystalline structures require crystallization water, which was lost by heating in open pans. While Inu monohydrate loses water to form the hemihydrate, the latter retains its crystallization water until its melting/decomposition. Spray-dried Inu and Mp(CA/Inu) did not show a melting peak and eventually showed a decomposition baseline drift, in agreement with the amorphous diffraction patterns.
Hermetic condition: In hermetic pans, no water loss was observed as expected (Figure 4c). The Tg was greatly reduced due to the moisture content of the powders and the well-known plasticizing effect of water on Inu [45,46] (Figure 4d). Spray-dried Inu showed an exothermic peak attributable to cold crystallization (Figure 4c), which was not observed for CA-Inu or Mp(CA/Inu), suggesting that this behavior is suppressed by the presence of CA. Regarding the melting process, Mp(CA/Inu) did not show a melting peak but instead exhibited a decomposition baseline drift, as observed under non-hermetic conditions. Spray-dried Inu showed an endothermic melting peak at 176 °C, arising from the melting of the cold crystallized fraction (Figure 4c). Finally, CA-Inu, despite not undergoing cold crystallization, showed a melting endothermic peak at 144 °C, confirming its semicrystalline nature as observed by XRD (Figure 3). While the melting of the cold crystallized spray-dried Inu (176 °C) was similar to the melting point reported for crystalline/semicrystalline Inu [45,46], the melting point of CA-Inu was considerably lower (144 °C). This behavior could be related to its isoforms previously reported [48], where Inu crystals are formed by helices of fructose residues. These showed higher melting points when the chains are longer, thus longer helices are formed. The CA substitution on the Inu chains could disrupt the helices packing, causing longer chains to behave as shorter chains with lower melting points.

3.3.3. Morphology

Figure 5 shows the morphology and external structure of Mp(CA/Inu) (Figure 5a–c) and CA-Inu (Figure 5d–f). Mp(CA/Inu) displayed a spherical shape with some agglomeration, but not aggregate formation. Most microparticles had a smooth surface, and no cracks or holes were observed, consistent with the high EE of CA obtained. The particle size ranged from 1 to 10 µm, with an average particle size of 3.20 ± 0.17 µm, measured by laser diffraction. CA-Inu showed flakes (Figure 5d) with superficial spiral shapes and high roughness (Figure 5e,f), which can be attributed to the helical conformation of semicrystalline Inu [44]. The roughness may be attributed to channels formed during the sublimation of frozen water, which is influenced by the freezing conditions and the solid amount in the freeze-dried dispersion.
Figure 5. Scanning electron microscopic photographs for caffeic acid–inulin microparticles (Mp(CA/Inu)) and inulin caffeate (CA-Inu) captured at magnification (a,d) 3000×, (b,e) 12,000×, and (c,f) 24,000×.

3.3.4. Solubility, Moisture, Hygroscopicity, and Water Activity

The solubility in water was 88.1% for Mp(CA/Inu) and 100% for CA-Inu, respectively (Table 2). This difference in solubility may be explained by the physical state of the powders and the drying method used. Mp(CA/Inu) was in an amorphous state, which has been described to hydrate quickly [49]. However, spray-dried amorphous microparticles may form clumps when exposed to water, reducing their solubility [12,50]. In contrast, although CA-Inu had a semicrystalline state, it exhibited a more porous structure (Figure 5d–f) because this powder was lyophilized, resulting in a high surface area that facilitates and accelerates hydration upon contact with water [51].
The final moisture depends primarily on both the inlet and outlet air temperatures during spray-drying, as well as the amount and type of encapsulating agent [52]. Mp(CA/Inu) had a moisture content of 4.4% (Table 2), in agreement with other polyphenol/Inu spray-dried systems [53]. Mp(CA/Inu) was spray-dried at 167 °C, with an outlet temperature of approximately 92 °C, ensuring that the spray-drying conditions resulted in a powder with low moisture content. In contrast, CA-Inu had a moisture content of 7.6%, which is related to the drying method used (freeze-drying). In a comparison of different drying methods (spray-, freeze-, and vacuum-drying) for encapsulating sea buckthorn juice using Inu as the encapsulation agent [52], moisture contents of 2.62% and 4.75% were found for spray-dried and freeze-dried powders, respectively. This trend is similar to the results obtained for Mp(CA/Inu) and Inu-CAF in this study.
The hygroscopicity assay for Mp(CA/Inu) showed a 13.5% increase in weight due to water absorption after being exposed for 7 days at 81% relative humidity (saturated sodium sulfate), which is within the range observed for amorphous Inu spray-dried microparticles [12,45]. The absorbed water may be physically adsorbed on the particles or integrated into the crystalline structure. In contrast, CA-Inu exhibited a much lower hygroscopicity, with a value of 5.1%. Despite both powders being composed with Inu and CA, the formation of a new polymer with CA-functionalized Inu accounts for this difference.
Finally, the water activity (aw) was 0.189 and 0.253 for Mp(CA/Inu) and CA-Inu, respectively. These values were below 0.3, ensuring the inhibition of microbial growth [54].

3.3.5. Antioxidant Activity

In ORAC measures, the antioxidant capacity is evaluated through a reaction between the antioxidants, a probe, and the oxygen-centered radicals generated by the thermal decomposition of AAPH. The oxygen-centered radicals react with a probe (fluorescein), leading to an oxidized product with different spectral behavior, allowing fluorescence detection. ORAC methodology has a priority hydrogen atom transfer mechanism, providing information on the stoichiometry of antioxidants [55].
Figure S6 shows the induction time (ti) for Trolox, CA-Inu, and CA at the same concentration (3.13 µM). As Ri depends on the AAPH concentration, and it was constant in the assay (18.75 mM), there is a direct proportional relationship between ti and n values. The n value for Trolox has been previously reported as two [38]. Considering that the ti of Trolox was 17.7 h, and that of CA-Inu and CA were approximately 1.6 and 2.4 times longer, respectively, CA-Inu and CA at 3.13 µM should be able to quench three and five molecules of the peroxyl radical. Although CA and CA-Inu contain the same number of –OH groups, the n value was lower for CA-Inu. In agreement with this result, the ORAC values (Table 2) of CA-Inu (21.0 ± 0.9 µmol Trolox/mg CA) were significantly (p < 0.05) lower than those of CA (28.0 ± 0.9 µmol Trolox/mg CA) and Mp(CA/Inu) (28.0 ± 0.5 µmol Trolox/mg CA), confirming that CA is completely available in the microparticles, whereas its antioxidant capacity decreased in the CA-Inu polymer. This reduction can be attributed to the covalent binding of CA to Inu in CA-Inu, which alters the resonance of the CA molecule, and, consequently, the availability of its hydroxyl groups, leading to a 25% decrease in its antioxidant capacity. Furthermore, the bulky moiety of Inu attached to the carboxylic group of the caffeic acid may produce a steric impediment, limiting the ability to quench peroxyl radicals [56].

3.4. In Vitro Simulated Digestion

The release profiles of CA from Mp(CA/Inu) and CA-Inu during in vitro simulated digestion are shown in Figure 6. CA was rapidly released from the amorphous Mp(CA/Inu), reaching 87% at the end of the oral phase. Although Inu can efficiently encapsulate phenolic compounds, it has poor retention in aqueous media, releasing water-soluble active compounds such as CA, even when Inu is neither dissolved nor metabolized [57]. CA levels remained practically constant during the gastric phase, since CA is stable under acidic conditions [58,59], and Inu is not degraded in the upper gastrointestinal tract. A slight decrease in CA was found at the beginning of the intestinal phase, which may be attributed to the binding of CA to the active site of pancreatic lipase by hydrogen bonds and π-stacking hydrophobic interactions [6]. At the end of the intestinal phase, around 80% of the CA from the Mp(CA/Inu) would be available for absorption. According to Olthof et al. (2001) [60], CA is absorbed up to 95% in the small intestine in humans, and therefore the colonic phase was not evaluated in the case of Mp(CA/Inu).
Figure 6. Caffeic acid in the digestion media (mg) and as a percentage of the initial CA content (%) for caffeic acid (CA), spray-dried caffeic acid–inulin microparticles (Mp(CA/Inu)), and inulin caffeate (CA-Inu). For the colonic phase, a sample without inulinase was assayed as a control.
CA-Inu showed a different CA release profile compared to Mp(CA/Inu) (Figure 6). CA was not detectable after oral and gastric digestion of CA-Inu, indicating high stability of CA when covalently bonded to the Inu backbone, despite ester bonds being labile in acidic conditions. In contrast, CA-Inu underwent partial hydrolysis during intestinal digestion, resulting in a 30% release of CA, due to the enzymatic activity of the pancreatic lipase. In agreement with this, it has been reported that the ester bonds of esterified polyphenols (such as hydroxytyrosol acetate, hydroxytyrosol decanoate, hydroxytyrosol stearate) break when these compounds are subjected to the intestinal phase of digestion [61,62].
After the intestinal phase, the colonic phase was simulated both with and without inulinase (as a control) to assess the effect of Inu degradation on CA release from CA-Inu. A significant amount of CA still bound to Inu reached the colonic phase of digestion. The release of CA from CA-Inu increased up to 9 h of digestion, after which CA levels remained nearly constant until the end of the colonic phase. The release of CA from CA-Inu in the colonic phase was higher with inulinase than in its absence (Figure 6) as a consequence of the hydrolysis of the Inu backbone by the enzyme, as confirmed by thin-layer chromatography (Figure S7). Throughout the colonic phase, the appearance and gradual increase in fructose were observed, while the CA-Inu spot progressively faded until it nearly disappeared.
Therefore, based on these results, the chemical binding of phenolic compounds, as CA in this work, proved to be a successful strategy for protecting the bioactive compound during the oral and gastric phases of digestion. This approach enabled a partial and gradual CA release during the intestinal phase while still retaining a significant amount of the bioactive in the colonic phase, where further release was promoted by enzymatic degradation of the Inu backbone. This study highlights the potential of designing functionalized biopolymers with phenolic compounds to achieve targeted release at specific sites, such as intestine and colon, where prebiotic and polyphenol-related activities can take place.

4. Conclusions

Inulin caffeate (CA covalently bound to Inu, CA-Inu) and CA–inulin microparticles (Mp(CA-Inu)) were characterized and subjected to in vitro simulated gastrointestinal digestion. Whether CA was introduced into Inu by physical mixing or chemical conjugation, the thermal properties remained largely unchanged, except that cold crystallization was fully suppressed. However, it noticeably influenced the release profile of CA during the digestion phases. Although the Mp(CA-Inu) exhibited a high encapsulation efficiency of CA, it led to a rapid release of CA during the early stages of gastrointestinal digestion. In contrast, CA-Inu showed targeted delivery of CA, particularly during the intestinal and colonic phases. This finding suggests that covalent binding of phenolic compounds to biopolymers can modify their release profile, promoting targeted delivery in these later stages of gastrointestinal digestion. Chemical binding could be a valuable strategy that combines antioxidant and prebiotic properties, highlighting its potential as a functional ingredient for colonic targeting. Given the positive results obtained in this study, future experiments would explore other green synthesis routes more suitable for food applications to obtain CA-Inu. In addition, the functionalization of Inu with other bioactive compounds should be investigated, along with the evaluation of their release behavior. Furthermore, core–shell particle structures could be used to delay the rapid release of CA during the oral and gastric phases in the case of Mp(CA-Inu).

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antiox15050591/s1. Figure S1: Full 1H NMR spectra of caffeic acid (CA), di-O-acetyl caffeic acid (di-O-CA), inulin (Inu), inulin di-O-acetylcaffeate (di-O-CA-Inu) and inulin–caffeate (CA-Inu). All spectra were obtained in d6-DMSO at 25 °C. Figure S2: Full FTIR spectra for inulin (Inu), CA–inulin microparticles Mp(CA/Inu), inulin–caffeate (CA-Inu), and caffeic acid (CA). Figure S3: Response surface graph for encapsulation efficiency of caffeic acid (CA) with inulin by spray-drying. Figure S4: X-ray diffraction patterns for caffeic acid–inulin microparticles (Mp(CA/Inu) with the lowest encapsulation efficiency obtained in the statistical design, before and after the removal of the non-encapsulated caffeic acid. Figure S5: Total heat flow of caffeic acid (CA) obtained by DSC. Figure S6: ORAC-FL profiles of (a) Trolox, (b) caffeic acid (CA), (c) inulin–caffeate (CA-Inu), and CA–inulin microparticles (Mp(CA/Inu)) at 3.13 µM. Figure S7: Thin-layer chromatography of the intestinal digestion after 2 h (I 2h), the colonic assay after 20 h without fructanase (C 20 h wo/F), the colonic assay after 20 h with inulinase (C 20 h w/F), and the colonic assay after 1 week with fructanase (C 1w w/F).

Author Contributions

Conceptualization, P.R.-H., E.S.-B., and P.R.; methodology, P.R.-H., A.Q.-C., B.G., E.S.-B., M.C.Z.-L., and P.R.; formal analysis, P.R.-H., A.Q.-C., and M.C.Z.-L.; investigation, P.R.-H., and A.Q.-C.; resources, E.S.-B., and P.R.; data curation, P.R.-H., A.Q.-C., and M.C.Z.-L.; writing—original draft preparation, P.R.-H., A.Q.-C., B.G., E.S.-B., M.C.Z.-L., and P.R.; writing—review and editing, P.R.-H., B.G., and P.R.; supervision, E.S.-B., and P.R.; project administration, P.R.-H., E.S.-B., and P.R.; funding acquisition, P.R.-H., and P.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by ANID (Fondecyt Postdoctorado 3210715; Fondecyt Regular Project 1221038; Fondequip Project EQM 200266), Chile.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article and Supplementary Materials. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
CACaffeic acid
InuInulin
CA-InuInulin–caffeate
Mp(CA/Inu)Spray-dried inulin microparticles
IBDInflammatory bowel disease
1H-NMRProton nuclear magnetic resonance
TTPTtriphenyl phosphine
DIADDiisopropyl azodicarboxylate
DMFAnhydrous N,N-Dimethylformamide
di-O-CA-InuInulin-3,4-diacetylcaffeate
di-O-CA3,4-diacetylcaffeic acid
ATRAttenuated Total Reflectance
DSDegree of substitution
CCDCentral Composite Design
EEEncapsulation efficiency
ANOVAAnalysis of variance
WAXSWide-angle X-ray scattering
MDSCModulated Differential Scanning Calorimetry
SEMScanning electron microscopy
ORACOxygen radical absorbance capacity
AAPH2,2′-Azobis(2-methylpropionamidine) dihydrochloride
AOXAntioxidants

References

  1. Muheyuddeen, G.; Verma, S.; Yadav, P.; Ahmad, T.; Khushtar, M.; Lin, C.-Y.; Li, D.-J.; Yaqub Khan, M.; Wang, M.-C. Bridging Tradition and Modern Medicine: Caffeic Acid as a Multifunctional Therapeutic Agent in 2025. J. Chem. Health Risks 2025, 15, 2513–2536. [Google Scholar]
  2. López-Herrador, S.; Corral-Sarasa, J.; González-García, P.; Morillas-Morota, Y.; Olivieri, E.; Jiménez-Sánchez, L.; Díaz-Casado, M.E. Natural Hydroxybenzoic and Hydroxycinnamic Acids Derivatives: Mechanisms of Action and Therapeutic Applications. Antioxidants 2025, 14, 711. [Google Scholar] [CrossRef] [Scilit]
  3. Wan, F.; Zhong, R.; Wang, M.; Zhou, Y.; Chen, Y.; Yi, B.; Hou, F.; Liu, L.; Zhao, Y.; Chen, L.; et al. Caffeic Acid Supplement Alleviates Colonic Inflammation and Oxidative Stress Potentially Through Improved Gut Microbiota Community in Mice. Front. Microbiol. 2021, 12, 784211. [Google Scholar] [CrossRef] [Scilit]
  4. Narita, Y.; Inouye, K. Degradation Kinetics of Chlorogenic Acid at Various pH Values and Effects of Ascorbic Acid and Epigallocatechin Gallate on Its Stability under Alkaline Conditions. J. Agric. Food Chem. 2013, 61, 966–972. [Google Scholar] [CrossRef] [Scilit]
  5. Liu, Y.; Li, H.; Liu, G.; Zhao, Y.; Luo, Y.; Xu, W.; Song, S.; Han, F. From Simulated Digestion to α-Glucosidase Inhibition: The Metabolic Fate of Wine Hydroxycinnamic Acids. Curr. Res. Food Sci. 2026, 12, 101356. [Google Scholar] [CrossRef] [Scilit]
  6. Martinez-Gonzalez, A.I.; Alvarez-Parrilla, E.; Díaz-Sánchez, Á.G.; De La Rosa, L.A.; Núñez-Gastélum, J.A.; Vazquez-Flores, A.A.; Gonzalez-Aguilar, G.A. In vitro Inhibition of Pancreatic Lipase by Polyphenols: A Kinetic, Fluorescence Spectroscopy and Molecular Docking Study. Food Technol. Biotechnol. 2017, 55, 519–530. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  7. Martinez-Gonzalez, A.I.; Díaz-Sánchez, Á.G.; De La Rosa, L.A.; Vargas-Requena, C.L.; Bustos-Jaimes, I.; Alvarez-Parrilla, E. Polyphenolic Compounds and Digestive Enzymes: In vitro Non-Covalent Interactions. Molecules 2017, 22, 669. [Google Scholar] [CrossRef] [Scilit]
  8. Nagar, E.E.; Okun, Z.; Shpigelman, A. In vitro Bioaccessibility of Polyphenolic Compounds: The Effect of Dissolved Oxygen and Bile. Food Chem. 2023, 404, 134490. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  9. Piñón-Balderrama, C.I.; Leyva-Porras, C.; Terán-Figueroa, Y.; Espinosa-Solís, V.; Álvarez-Salas, C.; Saavedra-Leos, M.Z. Encapsulation of Active Ingredients in Food Industry by Spray-Drying and Nano Spray-Drying Technologies. Processes 2020, 8, 889. [Google Scholar] [CrossRef] [Scilit]
  10. Morelo, G.; Giménez, B.; Márquez-Ruiz, G.; Holgado, F.; Romero-Hasler, P.; Soto-Bustamante, E.; Robert, P. Influence of the Physical State of Spray-Dried Flavonoid-Inulin Microparticles on Oxidative Stability of Lipid Matrices. Antioxidants 2019, 8, 520. [Google Scholar] [CrossRef] [Scilit]
  11. Palma, M.; García, P.; Márquez-Ruiz, G.; Vergara, C.; Robert, P. Release Kinetics of Flavonoids in Methyl Linoleate from Microparticles Designed with Inulin and Channelizing Agent. Food Res. Int. 2014, 64, 99–105. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  12. Quintriqueo-Cid, A.; Giménez, B.; Romero-Hasler, P.; Soto-Bustamante, E.; Lozano-Sánchez, J.; Robert, P. Influence of the Crystallinity on the Physicochemical Properties of Spray-Dried Quercetin-Inulin Microparticles and Their Performance during in vitro Digestion. Food Chem. 2024, 434, 137325. [Google Scholar] [CrossRef] [Scilit]
  13. González, E.; Gómez-Caravaca, A.M.; Giménez, B.; Cebrián, R.; Maqueda, M.; Parada, J.; Martínez-Férez, A.; Segura-Carretero, A.; Robert, P. Role of Maltodextrin and Inulin as Encapsulating Agents on the Protection of Oleuropein during in vitro Gastrointestinal Digestion. Food Chem. 2020, 310, 125976. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  14. Michalska, A.; Wojdyło, A.; Brzezowska, J.; Majerska, J.; Ciska, E. The Influence of Inulin on the Retention of Polyphenolic Compounds during the Drying of Blackcurrant Juice. Molecules 2019, 24, 4167. [Google Scholar] [CrossRef] [Scilit]
  15. Agatha, R.; Maryati, Y.; Susilowati, A.; Aspiyanto, A.; Devi, A.F.; Mulyani, H.; Budiari, S.; Filailla, E.; Rahmawati, D.; Artanti, N. Effect of Type and Concentration of Encapsulating Agents on Physicochemical, Phytochemical, and Antioxidant Properties of Red Dragon Fruit Kombucha Powdered Beverage. Indones. J. Appl. Chem. 2021, 23, 7–15. [Google Scholar] [CrossRef]
  16. Gomes, J.; Serrano, C.; Oliveira, C.; Dias, A.; Moldão, M. Thermal and Light Stability of Anthocyanins from Strawberry By-Products Non-Encapsulated and Encapsulated with Inulin. Acta Sci. Pol. Technol. Aliment. 2021, 20, 79–92. [Google Scholar] [CrossRef] [Scilit]
  17. Pettinato, M.; Aliakbarian, B.; Casazza, A.A.; Perego, P. Encapsulation of Antioxidants from Spent Coffee Ground Extracts by Spray Drying. Chem. Eng. Trans. 2017, 57, 1219–1224. [Google Scholar] [CrossRef] [Scilit]
  18. Petrova, P.; Petrov, K. Prebiotic–Probiotic Relationship: The Genetic Fundamentals of Polysaccharides Conversion by Bifidobacterium and Lactobacillus genera. In Food Bioconversion; Academic Press: Cambridge, MA, USA, 2017; Volume 2, pp. 237–278. [Google Scholar] [CrossRef] [Scilit]
  19. Mensink, M.A.; Frijlink, H.W.; Van Der Voort Maarschalk, K.; Hinrichs, W.L.J. Inulin, a Flexible Oligosaccharide I: Review of Its Physicochemical Characteristics. Carbohydr. Polym. 2015, 130, 405–419. [Google Scholar] [CrossRef] [Scilit]
  20. Xie, M.; Tian, Y.; Zhang, L.; Yu, M. Comparative Evaluation of Inulin and High-Ester Pectin for Microencapsulation of Bacillus coagulans TBC-169: Characterization and Probiotic Application in Peanut Butter Formulation. Foods 2025, 14, 2151. [Google Scholar] [CrossRef] [Scilit]
  21. Canazza, E.; Grauso, M.; Mihaylova, D.; Lante, A. Techno-Functional Properties and Applications of Inulin in Food Systems. Gels 2025, 11, 829. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  22. Alonso-Allende, J.; Milagro, F.I.; Aranaz, P. Health Effects and Mechanisms of Inulin Action in Human Metabolism. Nutrients 2024, 16, 2935. [Google Scholar] [CrossRef] [Scilit]
  23. Qin, Y.Q.; Wang, L.Y.; Yang, X.Y.; Xu, Y.J.; Fan, G.; Fan, Y.G.; Ren, J.N.; An, Q.; Li, X. Inulin: Properties and Health Benefits. Food Funct. 2023, 14, 2948–2968. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  24. Ghali, E.N.H.K.; Pranav; Chauhan, S.C.; Yallapu, M.M. Inulin-Based Formulations as an Emerging Therapeutic Strategy for Cancer: A Comprehensive Review. Int. J. Biol. Macromol. 2024, 259, 129216. [Google Scholar] [CrossRef] [Scilit]
  25. Wu, J.; Wang, L.; Lu, H.; Huo, Y.; Guo, Z.; Cheng, Y.; Li, Y.; Wang, Y.; Li, C. Inulin Hydrogel Loaded with Self-Assembled Nanoparticles of Curcumin and Glycyrrhizic Acid for Inflammatory Bowel Disease Treatment via Anti-Inflammation, Antioxidation, and Microbiota Modulation. Mol. Pharm. 2025, 22, 5410–5427. [Google Scholar] [CrossRef] [Scilit]
  26. Singh, M.; Rani, H.; Chopra, H.K. Synthetic Development in Inulin Modification and Its Applications. Curr. Org. Chem. 2024, 28, 1551–1566. [Google Scholar] [CrossRef] [Scilit]
  27. Díaz-Ramos, D.I.; Jiménez-Fernández, M.; García-Barradas, O.; Ortiz-Basurto, R.I.; Fouconnier, B. Chemical Modification Methods for Inulin- and Agavin-Type Fructans: Synthesis, Characterization, and Biofunctional Activity: A Review. Molecules 2025, 30, 2672. [Google Scholar] [CrossRef] [Scilit]
  28. Chen, Q.; Huang, J.; Gou, J.; Ren, Q.; Yuan, L. Inulin as Carriers for Renal Targeting Delivery of Ferulic Acid. Int. J. Biol. Macromol. 2020, 154, 654–660. [Google Scholar] [CrossRef] [Scilit]
  29. López-Molina, D.; Chazarra, S.; How, C.W.; Pruidze, N.; Navarro-Perán, E.; García-Cánovas, F.; García-Ruiz, P.A.; Rojas-Melgarejo, F.; Rodríguez-López, J.N. Cinnamate of Inulin as a Vehicle for Delivery of Colonic Drugs. Int. J. Pharm. 2015, 479, 96–102. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  30. Torlopov, M.A.; Udoratina, E.V.; Kuchin, A.V. Synthesis of Inulin Esters of Phenylcarboxylic Acids. Russ. J. Org. Chem. 2013, 49, 702–706. [Google Scholar] [CrossRef] [Scilit]
  31. Touaibia, M.; Guay, M. Natural Product Total Synthesis in the Organic Laboratory: Total Synthesis of Caffeic Acid Phenethyl Ester (CAPE), A Potent 5-Lipoxygenase Inhibitor from Honeybee Hives. J. Chem. Educ. 2011, 88, 473–475. [Google Scholar] [CrossRef] [Scilit]
  32. Fochetti, A.; Villanova, N.; Lombardi, A.; Lelli, V.; Gazzilli, Y.; Timperio, A.M.; Fabrizi, G.; Bernini, R. Synthesis of Novel Bioactive Lipophilic Hydroxyalkyl Esters and Diesters Based on Hydroxyphenylacetic Acids. Molecules 2025, 30, 3087. [Google Scholar] [CrossRef] [Scilit]
  33. Blasco, P.; Ståhle, J.; Thorsheim, K.; Furevi, A.; Siegbahn, A.; Tykesson, E.; Westergren-Thorsson, G.; Ellervik, U.; Widmalm, G. Synthesis, Conformational Analysis and Biological Activity of Xylopyranosyl Sulfur-Containing Glycosides: Dependence of Sulfur Atom Configuration. RSC Adv. 2025, 15, 18010–18020. [Google Scholar] [CrossRef] [Scilit]
  34. Ellervik, U.; Magnusson, G. Guanidine/Guanidinium Nitrate; a Mild and Selective O-Deacetylation Reagent That Leaves the N-Troc Group Intact. Tetrahedron Lett. 1997, 38, 1627–1628. [Google Scholar] [CrossRef] [Scilit]
  35. Lozada-Lawag, I.; Nolden, E.S.; Schaper, A.A.M.; Lim, L.Y.; Locher, C. A Modified Folin-Ciocalteu Assay for the Determination of Total Phenolics Content in Honey. Appl. Sci. 2023, 13, 2135. [Google Scholar] [CrossRef] [Scilit]
  36. Geranpour, M.; Assadpour, E.; Jafari, S.M. Recent Advances in the Spray Drying Encapsulation of Essential Fatty Acids and Functional Oils. Trends Food Sci. Technol. 2020, 102, 71–90. [Google Scholar] [CrossRef] [Scilit]
  37. Fernández Moreno, K.; Maturana, G.; Blanco-Haros, S.; Norambuena-Jopia, U.; Valenzuela-Barra, G.; Zúñiga-López, M.C.; Bravo Garrido, J. Determination of Bioactive Compounds, Antioxidant Capacity, Safety Assessment, and Antimicrobial Effect of Tristerix corymbosus Extracts. Molecules 2025, 30, 4610. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  38. Takashima, M.; Horie, M.; Shichiri, M.; Hagihara, Y.; Yoshida, Y.; Niki, E. Assessment of Antioxidant Capacity for Scavenging Free Radicals in vitro: A Rational Basis and Practical Application. Free Radic. Biol. Med. 2012, 52, 1242–1252. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  39. Pozo-Martínez, J.; Vázquez-Rodríguez, S.; Olea-Azar, C.; Moncada-Basualto, M. Evaluation of ORAC Methodologies in Determination of Antioxidant Capacity of Binary Combinations of Quercetin and 3-(3,4,5-Trihydroxybenzoyl) Coumarin Derivatives. Arab. J. Chem. 2022, 15, 104298. [Google Scholar] [CrossRef] [Scilit]
  40. Brodkorb, A.; Egger, L.; Alminger, M.; Alvito, P.; Assunção, R.; Ballance, S.; Bohn, T.; Bourlieu-Lacanal, C.; Boutrou, R.; Carrière, F.; et al. INFOGEST Static in vitro Simulation of Gastrointestinal Food Digestion. Nat. Protoc. 2019, 14, 991–1014. [Google Scholar] [CrossRef] [Scilit]
  41. de Armas-Ricard, M.; Ruiz-Reyes, E.; Ramírez-Rodríguez, O. Caffeates and Caffeamides: Synthetic Methodologies and Their Antioxidant Properties. Int. J. Med. Chem. 2019, 2019, 2592609. [Google Scholar] [CrossRef] [Scilit]
  42. Cai, H.; Huang, X.; Xu, S.; Shen, H.; Zhang, P.; Huang, Y.; Jiang, J.; Sun, Y.; Jiang, B.; Wu, X.; et al. Discovery of Novel Hybrids of Diaryl-1,2,4-Triazoles and Caffeic Acid as Dual Inhibitors of Cyclooxygenase-2 and 5-Lipoxygenase for Cancer Therapy. Eur. J. Med. Chem. 2016, 108, 89–103. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  43. Desai, N.M.; Haware, D.J.; Basavaraj, K.; Murthy, P.S. Microencapsulation of Antioxidant Phenolic Compounds from Green Coffee. Prep. Biochem. Biotechnol. 2019, 49, 400–406. [Google Scholar] [CrossRef] [Scilit]
  44. André, I.; Mazeau, K.; Tvaroska, I.; Putaux, J.L.; Winter, W.T.; Taravel, F.R.; Chanzy, H. Molecular and Crystal Structures of Inulin from Electron Diffraction Data. Macromolecules 1996, 29, 4626–4635. [Google Scholar] [CrossRef] [Scilit]
  45. Ronkart, S.N.; Paquot, M.; Fougnies, C.; Deroanne, C.; Blecker, C.S. Effect of Water Uptake on Amorphous Inulin Properties. Food Hydrocoll. 2009, 23, 922–927. [Google Scholar] [CrossRef] [Scilit]
  46. Kawai, K.; Fukami, K.; Thanatuksorn, P.; Viriyarattanasak, C.; Kajiwara, K. Effects of Moisture Content, Molecular Weight, and Crystallinity on the Glass Transition Temperature of Inulin. Carbohydr. Polym. 2011, 83, 934–939. [Google Scholar] [CrossRef] [Scilit]
  47. Glibowski, P.; Bukowska, A. The Effect of pH, Temperature and Heating Time on Inulin Chemical Stability. Acta Sci. Pol. Technol. Aliment. 2011, 10, 189–196. [Google Scholar]
  48. Cooper, P.D.; Barclay, T.G.; Ginic-Markovic, M.; Gerson, A.R.; Petrovsky, N. Inulin Isoforms Differ by Repeated Additions of One Crystal Unit Cell. Carbohydr. Polym. 2014, 103, 392–397. [Google Scholar] [CrossRef] [Scilit]
  49. Botrel, D.A.; Rodrigues, I.C.B.; de Souza, H.J.B.; de Barros Fernandes, R.V. Application of Inulin in Thin-Layer Drying Process of Araticum (Annona crassiflora) Pulp. LWT-Food Sci. Technol. 2016, 69, 32–39. [Google Scholar] [CrossRef] [Scilit]
  50. Glibowski, P.; Pikus, S. Amorphous and Crystal Inulin Behavior in a Water Environment. Carbohydr. Polym. 2011, 83, 635–639. [Google Scholar] [CrossRef] [Scilit]
  51. Silva, E.K.; Meireles, M.A.A. Influence of the Degree of Inulin Polymerization on the Ultrasound-Assisted Encapsulation of Annatto Seed Oil. Carbohydr. Polym. 2015, 133, 578–586. [Google Scholar] [CrossRef] [Scilit]
  52. Tkacz, K.; Wojdyło, A.; Michalska-Ciechanowska, A.; Turkiewicz, I.P.; Lech, K.; Nowicka, P. Influence Carrier Agents, Drying Methods, Storage Time on Physico-Chemical Properties and Bioactive Potential of Encapsulated Sea Buckthorn Juice Powders. Molecules 2020, 25, 3801. [Google Scholar] [CrossRef] [Scilit]
  53. Ferrer-Sierra, M.; Rodríguez-López, P.; Leyva-Jiménez, F.J.; Borras-Linares, I.; Giacomazza, D.; Fredes, C.; Canales, P.S.R.; Segura-Carretero, A.; Lozano-Sánchez, J. Encapsulation Technologies Applied to Bioactive Phenolic Compounds and Probiotics with Potential Application on Chronic Inflammation. In Current Advances for Development of Functional Foods Modulating Inflammation and Oxidative Stress; Academic Press: Cambridge, MA, USA, 2022; pp. 447–476. [Google Scholar] [CrossRef] [Scilit]
  54. Mar, J.M.; da Silva, L.S.; Lira, A.C.; Kinupp, V.F.; Yoshida, M.I.; Moreira, W.P.; Bruginski, E.; Campos, F.R.; Machado, M.B.; de Souza, T.P.; et al. Bioactive Compounds-Rich Powders: Influence of Different Carriers and Drying Techniques on the Chemical Stability of the Hibiscus acetosella Extract. Powder Technol. 2020, 360, 383–391. [Google Scholar] [CrossRef] [Scilit]
  55. Ou, B.; Hampsch-Woodill, M.; Prior, R.L. Development and Validation of an Improved Oxygen Radical Absorbance Capacity Assay Using Fluorescein as the Fluorescent Probe. J. Agric. Food Chem. 2001, 49, 4619–4626. [Google Scholar] [CrossRef] [Scilit]
  56. Pérez-Cruz, K.; Moncada-Basualto, M.; Morales-Valenzuela, J.; Barriga-González, G.; Navarrete-Encina, P.; Núñez-Vergara, L.; Squella, J.A.; Olea-Azar, C. Synthesis and Antioxidant Study of New Polyphenolic Hybrid-Coumarins. Arab. J. Chem. 2018, 11, 525–537. [Google Scholar] [CrossRef] [Scilit]
  57. Walz, M.; Hagemann, D.; Trentzsch, M.; Weber, A.; Henle, T. Degradation Studies of Modified Inulin as Potential Encapsulation Material for Colon Targeting and Release of Mesalamine. Carbohydr. Polym. 2018, 199, 102–108. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  58. Gayoso, L.; Claerbout, A.S.; Calvo, M.I.; Cavero, R.Y.; Astiasarán, I.; Ansorena, D. Bioaccessibility of Rutin, Caffeic Acid and Rosmarinic Acid: Influence of the in vitro Gastrointestinal Digestion Models. J. Funct. Foods 2016, 26, 428–438. [Google Scholar] [CrossRef] [Scilit]
  59. Pineda-Vadillo, C.; Nau, F.; Dubiard, C.G.; Cheynier, V.; Meudec, E.; Sanz-Buenhombre, M.; Guadarrama, A.; Tóth, T.; Csavajda, É.; Hingyi, H.; et al. In vitro Digestion of Dairy and Egg Products Enriched with Grape Extracts: Effect of the Food Matrix on Polyphenol Bioaccessibility and Antioxidant Activity. Food Res. Int. 2016, 88, 284–292. [Google Scholar] [CrossRef] [Scilit]
  60. Olthof, M.R.; Hollman, P.C.H.; Katan, M.B. Chlorogenic Acid and Caffeic Acid Are Absorbed in Humans. J. Nutr. 2001, 131, 66–71. [Google Scholar] [CrossRef] [Scilit]
  61. Pereira-Caro, G.; Sarriá, B.; Madrona, A.; Espartero, J.L.; Escuderos, M.E.; Bravo, L.; Mateos, R. Digestive Stability of Hydroxytyrosol, Hydroxytyrosyl Acetate and Alkyl Hydroxytyrosyl Ethers. Int. J. Food Sci. Nutr. 2012, 63, 703–707. [Google Scholar] [CrossRef] [Scilit]
  62. Jordânia Silva, T.; Ramírez-Carrasco, P.; Romero-Hasler, P.; Soto-Bustamante, E.; Barrera-Arellano, D.; Robert, P.; Giménez, B. Soybean Oil Organogelled Emulsions as Oral Delivery Systems of Hydroxytyrosol and Hydroxytyrosol Alkyl Esters. Food Chem. 2022, 379, 132182. [Google Scholar] [CrossRef] [Scilit]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.